open access

Vol 67, No 5 (2016)
Postgraduate education
Published online: 2016-10-31
Submitted: 2016-04-26
Accepted: 2016-06-14
Get Citation

Congenital hypothyroidism — Polish recommendations for therapy, treatment monitoring, and screening tests in special categories of neonates with increased risk of hypothyroidism

Anna Małgorzata Kucharska, Iwona Beń- Skowronek, Mieczysław Walczak, Mariusz Ołtarzewski, Mieczysław Szalecki, Teresa Jackowska, Andrzej Lewiński, Artur Bossowski
DOI: 10.5603/EP.2016.0062
·
Endokrynologia Polska 2016;67(5):536-547.

open access

Vol 67, No 5 (2016)
Postgraduate education
Published online: 2016-10-31
Submitted: 2016-04-26
Accepted: 2016-06-14

Abstract

Proper treatment of congenital hypothyroidism warrants normal intellectual and physical development. This paper introduces the principles of treatment of congenital hypothyroidism, the recommended levothyroxine dosage, and the aims of therapy with its justification. The principles of treatment, specialist care of the patient, and methods used to evaluate therapeutic effects are described. Based on these data, recommendations concerning treatment and its monitoring in patients with congenital hypothyroidism are formulated. The paper also highlights the importance of educating the patients and/or their caretakers as one of the basic components of an effective therapy. The interpretation of screening tests in preterm neonates is provided as well. In the current screening program in preterm children TSH was determined between days three and five of life and then after three weeks. During this time TSH values are frequently low because of the immaturity of the hypothalamic-pituitary axis. Due to the increased risk of primary and secondary hypothyroidism in preterm and low birth weight babies the determination of TSH and fT4 between days three and five of life is recommended, irrespective of the screening test. (Endokrynol Pol 2016; 67 (5): 536–547)

Abstract

Proper treatment of congenital hypothyroidism warrants normal intellectual and physical development. This paper introduces the principles of treatment of congenital hypothyroidism, the recommended levothyroxine dosage, and the aims of therapy with its justification. The principles of treatment, specialist care of the patient, and methods used to evaluate therapeutic effects are described. Based on these data, recommendations concerning treatment and its monitoring in patients with congenital hypothyroidism are formulated. The paper also highlights the importance of educating the patients and/or their caretakers as one of the basic components of an effective therapy. The interpretation of screening tests in preterm neonates is provided as well. In the current screening program in preterm children TSH was determined between days three and five of life and then after three weeks. During this time TSH values are frequently low because of the immaturity of the hypothalamic-pituitary axis. Due to the increased risk of primary and secondary hypothyroidism in preterm and low birth weight babies the determination of TSH and fT4 between days three and five of life is recommended, irrespective of the screening test. (Endokrynol Pol 2016; 67 (5): 536–547)

Get Citation

Keywords

congenital hypothyroidism; treatment; monitoring; screening tests; premature neonates; low birth weight

About this article
Title

Congenital hypothyroidism — Polish recommendations for therapy, treatment monitoring, and screening tests in special categories of neonates with increased risk of hypothyroidism

Journal

Endokrynologia Polska

Issue

Vol 67, No 5 (2016)

Pages

536-547

Published online

2016-10-31

DOI

10.5603/EP.2016.0062

Bibliographic record

Endokrynologia Polska 2016;67(5):536-547.

Keywords

congenital hypothyroidism
treatment
monitoring
screening tests
premature neonates
low birth weight

Authors

Anna Małgorzata Kucharska
Iwona Beń- Skowronek
Mieczysław Walczak
Mariusz Ołtarzewski
Mieczysław Szalecki
Teresa Jackowska
Andrzej Lewiński
Artur Bossowski

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl